ATE59290T1 - Stabile injizierbare arzneiformulierung des 1,4- dihydroxy-5,8-bis((2-(hydroxyaethylamino)|thyl)amino)anthrachinondihydrochlorids. - Google Patents

Stabile injizierbare arzneiformulierung des 1,4- dihydroxy-5,8-bis((2-(hydroxyaethylamino)|thyl)amino)anthrachinondihydrochlorids.

Info

Publication number
ATE59290T1
ATE59290T1 AT87102448T AT87102448T ATE59290T1 AT E59290 T1 ATE59290 T1 AT E59290T1 AT 87102448 T AT87102448 T AT 87102448T AT 87102448 T AT87102448 T AT 87102448T AT E59290 T1 ATE59290 T1 AT E59290T1
Authority
AT
Austria
Prior art keywords
hydroxyaethylamino
anthrachinonedihydrochloride
thyl
dihydroxy
bis
Prior art date
Application number
AT87102448T
Other languages
English (en)
Inventor
Pradeep V Niphadkar
Narendra R Desai
Paul N Jones
Kieran G Mooney
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ATE59290T1 publication Critical patent/ATE59290T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)
AT87102448T 1986-03-07 1987-02-20 Stabile injizierbare arzneiformulierung des 1,4- dihydroxy-5,8-bis((2-(hydroxyaethylamino)|thyl)amino)anthrachinondihydrochlorids. ATE59290T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US83724386A 1986-03-07 1986-03-07
EP87102448A EP0236822B1 (de) 1986-03-07 1987-02-20 Stabile injizierbare Arzneiformulierung des 1,4-Dihydroxy-5,8-bis((2-(hydroxyäthylamino)-äthyl)amino)anthrachinondihydrochlorids

Publications (1)

Publication Number Publication Date
ATE59290T1 true ATE59290T1 (de) 1991-01-15

Family

ID=25273922

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87102448T ATE59290T1 (de) 1986-03-07 1987-02-20 Stabile injizierbare arzneiformulierung des 1,4- dihydroxy-5,8-bis((2-(hydroxyaethylamino)|thyl)amino)anthrachinondihydrochlorids.

Country Status (21)

Country Link
EP (1) EP0236822B1 (de)
JP (1) JPH0717500B2 (de)
KR (1) KR900002030B1 (de)
AT (1) ATE59290T1 (de)
AU (1) AU593330B2 (de)
CA (1) CA1283607C (de)
DE (1) DE3766984D1 (de)
DK (1) DK166754B1 (de)
ES (1) ES2033247T3 (de)
FI (1) FI84977C (de)
GR (1) GR3001503T3 (de)
HK (1) HK63991A (de)
HU (1) HU199286B (de)
IE (1) IE60025B1 (de)
IL (1) IL81681A (de)
NO (1) NO173635C (de)
NZ (1) NZ219454A (de)
PH (1) PH22808A (de)
PT (1) PT84398B (de)
SG (1) SG45292G (de)
ZA (1) ZA871652B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0705601B1 (de) * 1994-10-04 2000-01-19 LOMAPHARM Rudolf Lohmann GmbH KG Pharmazeutische Fabrik Lösungen von Anthrachinonen zur parenteralen Applikation
DE19818802A1 (de) * 1998-04-27 1999-10-28 Dresden Arzneimittel Stabile Mitoxantron-Lösungen
TW200526268A (en) * 2003-12-17 2005-08-16 Takeda Pharmaceutical Injectable composition
CN103260616B (zh) * 2010-12-09 2015-09-09 丸石制药株式会社 对乙酰氨基酚的稳定化剂
CN114601791B (zh) * 2020-12-08 2023-09-19 成都倍特药业股份有限公司 一种盐酸米托蒽醌液体制剂及其制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3230143A (en) * 1965-05-14 1966-01-18 Merck & Co Inc Antihypertensive injection methods using acid addition salts of alkyl esters of alpha-methyl-3, 4-dihy-droxyphenylalanine
US4223022A (en) * 1978-01-16 1980-09-16 Schering Corporation Stabilized aminoglycoside antibiotic formulations
US4328213A (en) * 1979-11-28 1982-05-04 Schering Corporation Stable injectable labetalol formulation
ATE48942T1 (de) * 1984-02-27 1990-01-15 American Cyanamid Co Verwendung von 1,4 bisubstituierten anthrachinonen zur herstellung von immunsuppressiva.

Also Published As

Publication number Publication date
GR3001503T3 (en) 1992-11-23
KR900002030B1 (ko) 1990-03-31
NZ219454A (en) 1989-04-26
EP0236822A2 (de) 1987-09-16
AU593330B2 (en) 1990-02-08
PH22808A (en) 1988-12-27
FI84977C (fi) 1992-02-25
AU6977387A (en) 1987-09-10
EP0236822A3 (en) 1989-01-11
JPH0717500B2 (ja) 1995-03-01
IL81681A0 (en) 1987-09-16
DE3766984D1 (de) 1991-02-07
CA1283607C (en) 1991-04-30
PT84398B (pt) 1989-10-04
EP0236822B1 (de) 1990-12-27
NO870950D0 (no) 1987-03-06
NO173635C (no) 1994-01-12
NO870950L (no) 1987-09-08
PT84398A (en) 1987-04-01
ES2033247T3 (es) 1993-03-16
IE60025B1 (en) 1994-05-18
KR870008581A (ko) 1987-10-19
FI870994L (fi) 1987-09-08
HUT47020A (en) 1989-01-30
SG45292G (en) 1992-06-12
DK116687D0 (da) 1987-03-06
DK116687A (da) 1987-09-08
DK166754B1 (da) 1993-07-12
HU199286B (en) 1990-02-28
HK63991A (en) 1991-08-23
IL81681A (en) 1991-01-31
JPS62265220A (ja) 1987-11-18
FI84977B (fi) 1991-11-15
ZA871652B (en) 1987-08-28
NO173635B (no) 1993-10-04
IE870569L (en) 1987-09-07
FI870994A0 (fi) 1987-03-06

Similar Documents

Publication Publication Date Title
IS3156A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK0539204T3 (da) Antivirale 4-substituerede-deoxy-2,3-didehydroderivater af alfa-D-neuraminsyre
SE8804629D0 (sv) New therapeutically active compounds
MX9203417A (es) Compuestos de diarilo antiateroescleroticos.
FR2695387B1 (fr) Nouveaux composés benzopyraniques, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
SE8404065D0 (sv) Novel biologically active compounds
ATE59290T1 (de) Stabile injizierbare arzneiformulierung des 1,4- dihydroxy-5,8-bis((2-(hydroxyaethylamino)|thyl)amino)anthrachinondihydrochlorids.
SE8600658D0 (sv) Novel composition of matter
SE8704097D0 (sv) Oral formulation of buspirone and salts thereof
PT86771A (pt) Process for preparing 4-substituted benzamide derivatives with anticonvulsant activity
ES2095714T3 (es) Nuevas amino-alquil-cromonas, sus procedimientos de preparacion y las composiciones farmaceuticas que las contienen.
NO179072C (no) Glutarsyrederivater, samt fremstilling derav
BR9706491A (pt) Compostos de elipticina processo para a sua preparação e composições farmacêuticas contendo os mesmos
ECSP961893A (es) (metil sulfonil) fenil -2-(5h)- furanomas como inhibidores de cox - 2''

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee